166 related articles for article (PubMed ID: 25244013)
1. A novel poly-naphthol compound ST104P suppresses angiogenesis by attenuating matrix metalloproteinase-2 expression in endothelial cells.
Ma YL; Lin SW; Fang HC; Chou KJ; Bee YS; Chu TH; Chang MC; Weng WT; Wu CY; Cho CL; Tai MH
Int J Mol Sci; 2014 Sep; 15(9):16611-27. PubMed ID: 25244013
[TBL] [Abstract][Full Text] [Related]
2. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
[TBL] [Abstract][Full Text] [Related]
3. 5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.
Zhu W; Fu A; Hu J; Wang T; Luo Y; Peng M; Ma Y; Wei Y; Chen L
Exp Mol Med; 2011 Mar; 43(3):146-52. PubMed ID: 21297378
[TBL] [Abstract][Full Text] [Related]
4. A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
Kwong WL; Lam KY; Lok CN; Lai YT; Lee PY; Che CM
Angew Chem Int Ed Engl; 2016 Oct; 55(43):13524-13528. PubMed ID: 27717148
[TBL] [Abstract][Full Text] [Related]
5. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
6. AGS-30, an andrographolide derivative, suppresses tumor angiogenesis and growth in vitro and in vivo.
Li J; Li F; Tang F; Zhang J; Li R; Sheng D; Lee SM; Zhou GC; Leung GP
Biochem Pharmacol; 2020 Jan; 171():113694. PubMed ID: 31706845
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.
Bhat TA; Moon JS; Lee S; Yim D; Singh RP
Indian J Exp Biol; 2011 Nov; 49(11):848-56. PubMed ID: 22126016
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
[TBL] [Abstract][Full Text] [Related]
9. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway.
Weng WT; Huang SC; Ma YL; Chan HH; Lin SW; Wu JC; Wu CY; Wen ZH; Wang EM; Wu CL; Tai MH
Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634
[TBL] [Abstract][Full Text] [Related]
10. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
Mu X; Shi W; Sun L; Li H; Jiang Z; Zhang L
Molecules; 2012 Jun; 17(6):6854-68. PubMed ID: 22669041
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells.
Zhao D; Qin C; Fan X; Li Y; Gu B
Eur J Pharmacol; 2014 Jan; 723():360-7. PubMed ID: 24239714
[TBL] [Abstract][Full Text] [Related]
12. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
13. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
14. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
15. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic and anticancer effects of baicalein derivatives based on transgenic zebrafish model.
Jiang X; Zhou J; Lin Q; Gong G; Sun H; Liu W; Guo Q; Feng F; Qu W
Bioorg Med Chem; 2018 Aug; 26(15):4481-4492. PubMed ID: 30098912
[TBL] [Abstract][Full Text] [Related]
18. Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells.
De Lorenzo MS; Alonso DF; Gomez DE
Anticancer Res; 2000; 20(1A):395-400. PubMed ID: 10769686
[TBL] [Abstract][Full Text] [Related]
19. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
Liu JJ; Huang TS; Cheng WF; Lu FJ
Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
[TBL] [Abstract][Full Text] [Related]
20. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
